Satya Shanbhag Waikato Cardiothoracic Unit

Slides:



Advertisements
Similar presentations
Statins in Renal Failure Andrea Fox Sunnybrook Health Science Center May 2010.
Advertisements

1. 2 The primary Objective of IDEAL LDL-C Simvastatin mg/d Atorvastatin 80 mg/d risk CHD In stable CHD patients IDEAL: The Incremental Decrease.
In Diabetics with Ischemic Heart Disease CABG revascularization is always superior? Dr. Paolo Ferrazzi.
Valsartan Antihypertensive Long-Term Use Evaluation Results
Professor Abdus Samad MD FACC Karachi Institute of Heart Diseases Karachi, Pakistan May 1, 2010.
Coronary Revascularisation in Patients With Diabetes Mellitus Dr Rod Stables The Cardiothoracic Centre Liverpool UK.
5 Years Results of Off-Pump VS On-Pump CABG 5 Years Results of Off-Pump VS On-Pump CABG Prospective Non-randomized Comparative Study Piya Cherntanomwong*,
VBWG IDEAL: The Incremental Decrease in End Points Through Aggressive Lipid Lowering Study.
Stent or Surgery: What is Best for a Woman ? Dr R H Stables Cardiothoracic Centre Liverpool UK.
Trans-Radial Approach for STEMI Evolution of TRA in single center Rationale behind increased TRA use Progression to use in STEMI Data analysis of STEMI.
G. Rainey Williams Symposium September 30, 2005 CABG in the Elderly Patient: On or Off pump? A Single Center Experience R. Nathan Grantham, M.D.
The Synergy between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery: The SYNTAX Study One Year Results of the PCI and CABG Registries.
HOPE: Heart Outcomes Prevention Evaluation study Purpose To evaluate whether the long-acting ACE inhibitor ramipril and/or vitamin E reduce the incidence.
Are all forms of total arterial revascularisation equal? A comparison of single versus bilateral internal thoracic artery grafting strategies. William.
Daniel I. Sessler Department of O UTCOMES R ESEARCH Cleveland Clinic on behalf of POISE-2 Investigators PeriOperative ISchemic Evaluation-2 Trial POISE-2POISE-2.
Prevention of Events with Angiotensin Converting Enzyme Inhibition (PEACE) Trial PEACE Trial Presented at The American Heart Association Scientific Sessions.
DIABETES INSTITUTE JOURNAL CLUB CARINA SIGNORI, D.O., M.P.H. DECEMBER 15, 2011 Atherothrombosis intervention in metabolic syndrome with low HDL/High Triglycerides:
R1 강민혜 / prof. 전숙. Introduction Patients with type 2 diabetes have a greatly increased risk of cardiovascular events. The morbidity and mortality related.
On and Off Pump Coronary Artery Bypass Grafting (CABG) David Kim Independent Research GT.
Date of download: 6/27/2016 Copyright © The American College of Cardiology. All rights reserved. From: Percutaneous Coronary Intervention Complications.
CABG IN DIABETICS DR. SEYED SAEED FARZAM. Introduction Patients with diabetes mellitus Increased incidence of CAD More extensive disease at angiography.
1 R1 임준욱 Anticoagulant and Antiplatelet Therapy Use in 426 Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention and Stent Implantation.
David J McCormack MFSTEd FRCSEd (CTh) Advanced Clinical Fellow
The ALERT Trial.
Single IMA {Single Arterial}
Reducing Adverse Outcomes after ACS in Patients with Diabetes Goals
Joseph Zacharias & Bilal Kirmani Lancashire Cardiac Centre Blackpool
Multi Modality Approach to Diagnosis of Ischemia in Post CABG Cases
PRESENTER NAME Waikato Cardiothoracic Unit Journal Club
Damian Gimpel Waikato Cardiothoracic Unit Journal Club
Health and Human Services National Heart, Lung, and Blood Institute
The Evidence For Conduit Choice
HOPE: Heart Outcomes Prevention Evaluation study
The IDEAL Study Reference
POISE-2 PeriOperative ISchemic Evaluation-2 Trial
Balloon-pump assisted Coronary Intervention Study (BCIS-1):
PMA Analysis of the CREST Trial Approvability of the RX Acculink Carotid Stent System for Revascularization of Carotid Artery Stenosis in Standard Surgical.
Liver only transplants in the UK Question 2: In terms of survival benefit.
RAAS Blockade: Focus on ACEI
Jeff Macemon Waikato Cardiothoracic Unit
Nishith Patel Waikato Cardiothoracic Unit
Systolic Blood Pressure Intervention Trial (SPRINT)
Configurations of Arterial Grafts:
Dabigatran in myocardial injury after noncardiac surgery
PROPPR Transfusion of Plasma, Platelets, and Red Blood Cells in a 1:1:1 vs a 1:1:2 Ratio and Mortality in Patients With Severe Trauma. 
Satya Shanbhag Waikato Cardiothoracic Unit
Dr. PJ Devereaux on behalf of POISE Investigators
Insights from the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT)
Diabetes Journal Club March 17, 2011
Preventive Angioplasty in Myocardial Infarction Trial
The Synergy between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery: The SYNTAX Study One Year Results of the PCI and CABG Registries.
Dr. PJ Devereaux on behalf of POISE Investigators
One-year clinical outcomes in older patients with non-ST elevation acute coronary syndrome undergoing coronary angiography: An analysis of the ICON1 study 
Coronary artery bypass grafting using the gastroepiploic artery in 1,000 patients  Hitoshi Hirose, MD, Atushi Amano, MD, Shuichirou Takanashi, MD, Akihito.
Five-Year Outcomes after Randomization to Transcatheter or Surgical Aortic Valve Replacement: Final Results of The PARTNER 1 Trial Michael J. Mack, MD.
Clonidine in Patients Having Noncardiac Surgery
Figure 1 Periprocedural myonecrosis and myocardial infarction after left main coronary artery revascularization with ... Figure 1 Periprocedural myonecrosis.
Long-term survival benefits of coronary artery bypass grafting and percutaneous transluminal angioplasty in patients with coronary artery disease  Robert.
A decade after the Surgical Treatment for Ischemic Heart Failure (STICH) trial: Weaving firm clinical recommendations from lessons learned  Robert E.
Volume 371, Issue 9627, Pages (May 2008)
Volume 378, Issue 9786, Pages (July 2011)
The Synergy between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery: The SYNTAX Study One Year Results of the PCI and CABG Registries.
ARISE Trial Aggressive Reduction of Inflammation Stops Events
Impact of Diabetes Mellitus on Long-term Outcomes in the
The Heart Rhythm Society Meeting Presented by Dr. Johan De Sutter
Unless provided in the caption above, the following copyright applies to the content of this slide: Published on behalf of the European Society of Cardiology.
FIELD: Primary outcome
Kaplan-Meier estimate of mortality in the two treatment strategies with significant difference between the two groups (log-rank test
Kaplan-Meier curves of ventricular arrhythmia–related events (A), death from MI (B), or both end points combined (C). Kaplan-Meier curves of ventricular.
Presenter Disclosure Information
Presentation transcript:

Satya Shanbhag Waikato Cardiothoracic Unit ART Trial Satya Shanbhag Waikato Cardiothoracic Unit

Introduction Use of BITA/BIMA graft for CABG has till now shown good long term benefit Pooled data show that BITA grafts decrease mortality by 20% at 10 years compared to single LIMA grafts BIMA grafts not widely adopted: difficult, cause increased sternal events and benefit not fully known through randomised studies

Methods Patients randomly assigned to undergo LIMA or BIMA graft (June 2004 –Dec 2007) Study in 28 cardiac centers in 7 countries F/U period up to 10 years (5 yrs interim analysis) Primary Outcome: Death from any cause in 10 yrs Secondary Outcome: Composite of death from any cause, MI and Stroke

Methods Statistics: Kaplan Meier with log rank correction, Cox proportional hazard model for HR Pre-specified sub group analysis for: age (<70 and >70), DM (yes/no), radial artery graft( yes/no), EF (<50% and >50%) and number of grafts (<3 and >3).

Author Conclusions The study is an interim analysis (at 5 yrs) of the ART trial At 5yrs no difference in primary and composite outcomes between the two group Higher sternal complication in the BIMA group

Study strengths Well conducted multi institutional randomised study The study met the required number of patients Some amount of blinding performed for selection Published in a reputed journal

Study weakness Interim analysis only- no definitive conclusion can be drawn The graft configuration not standardised 25% of patients >70 yr old underwent complex BIMA grafts The trial may not find significance because 16.4% of BIMA patients did not get the graft.

Study weakness Sternal complication high due to 49% BIMA having pedicled grafts Doubtful lateral wall revascularisation due to 49%pedicled BIMA More than 20% of LIMA patients received supplemental radial artery graft- shown to be better than single graft (possible equivalent to BIMA)

What are the evidence/guidelines?

What are the evidence/guidelines?

LIMA vs BIMA

RIMA vs Radial

CABG: long term graft patency

Conclusions BIMA and total arterial graft has its own use and advantages These should be offered for the ideal candidate patients Radial artery graft offers an alternative to RIMA and is as effective Further randomised studies required with long term f/u